Page 3 | Certara

Blog

Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions

Explore how PMx regulatory submissions, exposure-response modeling, and strategic pharmacometrics planning support successful and timely…

CertaraDecember 29, 2025

Fact Sheet

Strategic Project Management for Accelerated Drug Development

Expert project leadership to keep complex programs on track, aligned, and moving forward—so you can…

CertaraDecember 23, 2025

Press Coverage

Pharma positions itself for 2026 amid an evolving US landscape

Explore how U.S. policy changes — including tariffs, onshoring, and Most Favored Nation pricing —…

CertaraDecember 22, 2025

Webinar

Alternative parameters in NCA using Phoenix WinNonlin

CertaraDecember 22, 2025

Conference

International PBPK Conference

certarastgDecember 22, 2025

Conference

MVA Oncology Network

CertaraDecember 19, 2025

Publication

A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection

This study synthesizes data from a large body of clinical trials to evaluate rates of…

CertaraDecember 18, 2025

Publication

A Tutorial on the Development of a Physiologically Inspired PKRO Model for Monoclonal Antibodies

This tutorial introduces the physiologically inspired PKRO (piPKRO) model - a streamlined, mechanistic framework for…

CertaraDecember 18, 2025

Poster

First-in-human dosing model for MDX2004, a novel trispecific CD3xCD28/4-1BB antibody-fusion protein for advanced malignancies

Learn how QSP modeling enabled safe, data-driven FIH dose prediction for the trispecific T-cell activator…

CertaraDecember 16, 2025